A citation-based method for searching scientific literature

Lingyun Ye, Xiaoxia Chen, Fei Zhou. Curr Opin Oncol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




MerTK mediates STAT3-KRAS/SRC-signaling axis for glioma stem cell maintenance.
Hyojin Eom, Neha Kaushik, Ki-Chun Yoo, Jin-Kyoung Shim, Munjin Kwon, Mi-Young Choi, Taeyoung Yoon, Seok-Gu Kang, Su-Jae Lee. Artif Cells Nanomed Biotechnol 2018
10
100

Comprehensive mapping of the human kinome to epidermal growth factor receptor signaling.
Kakajan Komurov, David Padron, Tzuling Cheng, Michael Roth, Kevin P Rosenblatt, Michael A White. J Biol Chem 2010
26
100

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer.
Canan Kasikara, Viralkumar Davra, David Calianese, Ke Geng, Thomas E Spires, Michael Quigley, Michael Wichroski, Ganapathy Sriram, Lucia Suarez-Lopez, Michael B Yaffe,[...]. Cancer Res 2019
43
100

Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib.
Shengzhi Xie, Yongwu Li, Xiaoyan Li, Linxiong Wang, Na Yang, Yadi Wang, Huafeng Wei. Oncotarget 2015
31
100

Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
Amir Tajbakhsh, Mehdi Rezaee, Petri T Kovanen, Amirhossein Sahebkar. Pharmacol Ther 2018
48
100

Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib.
Nicolas A Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques, Emmanuel Telle, Patricia Santofimia-Castaño, María Teresa Borrello, Eduardo Chuluyan, Nelson Dusetti,[...]. Clin Cancer Res 2020
10
100

Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
Frank C Cackowski, Matthew R Eber, James Rhee, Ann M Decker, Kenji Yumoto, Janice E Berry, Eunsohl Lee, Yusuke Shiozawa, Younghun Jung, Julio A Aguirre-Ghiso,[...]. J Cell Biochem 2017
41
100

Gossypol overcomes EGFR-TKIs resistance in non-small cell lung cancer cells by targeting YAP/TAZ and EGFRL858R/T790M.
Jian Xu, Guo-Yuan Zhu, Dai Cao, Hao Pan, Ying-Wei Li. Biomed Pharmacother 2019
7
100

TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.
Rachel M A Linger, Amy K Keating, H Shelton Earp, Douglas K Graham. Adv Cancer Res 2008
452
100

Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients.
Lin Tong, Xue-Xi Yang, Min-Feng Liu, Guang-Yu Yao, Jian-Yu Dong, Chang-Sheng Ye, Ming Li. Asian Pac J Cancer Prev 2012
17
100

The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy.
Céline Clémenson, Cyrus Chargari, Winchygn Liu, Michele Mondini, Charles Ferté, Mike F Burbridge, Valérie Cattan, Anne Jacquet-Bescond, Eric Deutsch. Mol Cancer Ther 2017
18
100

The potential role of YAP in Axl-mediated resistance to EGFR tyrosine kinase inhibitors.
Sarah Saab, Olin Shih-Shin Chang, Kentaro Nagaoka, Mien-Chie Hung, Hirohito Yamaguchi. Am J Cancer Res 2019
7
100


Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer.
Hatim Husain, Michael Scur, Ayesha Murtuza, Nam Bui, Brian Woodward, Razelle Kurzrock. Mol Cancer Ther 2017
25
100

The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia.
Katherine A Minson, Catherine C Smith, Deborah DeRyckere, Clara Libbrecht, Alisa B Lee-Sherick, Madeline G Huey, Elisabeth A Lasater, Gregory D Kirkpatrick, Michael A Stashko, Weihe Zhang,[...]. JCI Insight 2016
29
100

A phase I trial to determine safety and pharmacokinetics of ASLAN002, an oral MET superfamily kinase inhibitor, in patients with advanced or metastatic solid cancers.
Aflah Roohullah, Adam Cooper, Anna J Lomax, Jennifer Aung, Alan Barge, Lilian Chow, Mark McHale, Jayesh Desai, James R Whittle, Ben Tran,[...]. Invest New Drugs 2018
14
100

Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
Ilseon Hwang, Jeong Won Kim, Kris Ylaya, Eun Joo Chung, Haruhisa Kitano, Candice Perry, Jun Hanaoka, Junya Fukuoka, Joon-Yong Chung, Stephen M Hewitt. J Transl Med 2020
16
100

Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma.
Jiale Wang, Tamara Mirzapoiazova, Yi-Hung Carol Tan, Ka Ming Pang, Alex Pozhitkov, Yingyu Wang, Yang Wang, Bolot Mambetsariev, Edward Wang, Mohd W Nasser,[...]. Cancer Biol Ther 2018
8
100

Unique Pro-Inflammatory Response of Macrophages during Apoptotic Cancer Cell Clearance.
Veronica Mendoza-Reinoso, Dah Youn Baek, Adrianne Kurutz, John R Rubin, Amy J Koh, Laurie K McCauley, Hernan Roca. Cells 2020
5
100

Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
Younghun Jung, Ann M Decker, Jingcheng Wang, Eunsohl Lee, Lulia A Kana, Kenji Yumoto, Frank C Cackowski, James Rhee, Peter Carmeliet, Laura Buttitta,[...]. Oncotarget 2016
22
100

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
Jennifer Schlegel, Maria J Sambade, Susan Sather, Stergios J Moschos, Aik-Choon Tan, Amanda Winges, Deborah DeRyckere, Craig C Carson, Dimitri G Trembath, John J Tentler,[...]. J Clin Invest 2013
97
100

EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors.
Dalia Ercan, Hwan Geun Choi, Cai-Hong Yun, Marzia Capelletti, Ting Xie, Michael J Eck, Nathanael S Gray, Pasi A Jänne. Clin Cancer Res 2015
227
100

Lung Cancer Statistics.
Lindsey A Torre, Rebecca L Siegel, Ahmedin Jemal. Adv Exp Med Biol 2016
931
100

UNC1062, a new and potent Mer inhibitor.
Jing Liu, Weihe Zhang, Michael A Stashko, Deborah Deryckere, Christopher T Cummings, Debra Hunter, Chao Yang, Chatura N Jayakody, Nancy Cheng, Catherine Simpson,[...]. Eur J Med Chem 2013
47
100

The cellular and molecular origin of tumor-associated macrophages.
Ruth A Franklin, Will Liao, Abira Sarkar, Myoungjoo V Kim, Michael R Bivona, Kang Liu, Eric G Pamer, Ming O Li. Science 2014
681
100

Epidermal growth factor receptor: Role in human cancer.
Prashanth Rajaram, Poornima Chandra, Smriti Ticku, B K Pallavi, K B Rudresh, Poorva Mansabdar. Indian J Dent Res 2017
25
100

Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC.
Paul Giroud, Sarah Renaudineau, Laura Gudefin, Alexandre Calcei, Thierry Menguy, Caroline Rozan, Jacques Mizrahi, Christophe Caux, Vanessa Duong, Jenny Valladeau-Guilemond. Front Immunol 2020
6
100

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
Suresh S Ramalingam, Johan Vansteenkiste, David Planchard, Byoung Chul Cho, Jhanelle E Gray, Yuichiro Ohe, Caicun Zhou, Thanyanan Reungwetwattana, Ying Cheng, Busyamas Chewaskulyong,[...]. N Engl J Med 2020
577
100

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.
Maureen Keller, Fatéméh Dubois, Sylvain Teulier, Alexandre P J Martin, Jérôme Levallet, Elodie Maille, Solenn Brosseau, Nicolas Elie, Alexander Hergovich, Emmanuel Bergot,[...]. J Exp Clin Cancer Res 2019
11
100

EGF-receptor specificity for phosphotyrosine-primed substrates provides signal integration with Src.
Michael J Begley, Cai-hong Yun, Christina A Gewinner, John M Asara, Jared L Johnson, Anthony J Coyle, Michael J Eck, Irina Apostolou, Lewis C Cantley. Nat Struct Mol Biol 2015
24
100

The role of epidermal growth factor receptor in cancer metastasis and microenvironment.
Takamitsu Sasaki, Kuniyasu Hiroki, Yuichi Yamashita. Biomed Res Int 2013
124
100

EGF receptor ligands.
Raymond C Harris, Eunkyung Chung, Robert J Coffey. Exp Cell Res 2003
540
100

STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers.
Yi-Fang Chang, Ken-Hong Lim, Ya-Wen Chiang, Zong-Lin Sie, Jungshan Chang, Ai-Sheng Ho, Chun-Chia Cheng. BMC Cancer 2019
8
100

MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.
Giovanni Musso, Maurizio Cassader, Franco De Michieli, Elena Paschetta, Silvia Pinach, Francesca Saba, Daria Bongiovanni, Luciana Framarin, Mara Berrutti, Nicola Leone,[...]. Hum Mol Genet 2017
14
100

TAM receptor signaling in immune homeostasis.
Carla V Rothlin, Eugenio A Carrera-Silva, Lidia Bosurgi, Sourav Ghosh. Annu Rev Immunol 2015
218
100

Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma.
Fa Yang, Yan Wei, Donghui Han, Yu Li, Shengjia Shi, Dian Jiao, Jieheng Wu, Qiang Zhang, Changhong Shi, Lijun Yang,[...]. Cancer Res 2020
9
100

EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression.
Shunli Peng, Rong Wang, Xiaojuan Zhang, Yueyun Ma, Longhui Zhong, Ke Li, Akihiro Nishiyama, Sachiko Arai, Seiji Yano, Wei Wang. Mol Cancer 2019
54
100

Loss of epidermal growth factor receptor in vascular smooth muscle cells and cardiomyocytes causes arterial hypotension and cardiac hypertrophy.
Barbara Schreier, Sindy Rabe, Bettina Schneider, Maria Bretschneider, Sebastian Rupp, Stefanie Ruhs, Joachim Neumann, Uwe Rueckschloss, Maria Sibilia, Michael Gotthardt,[...]. Hypertension 2013
41
100

Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors.
Adil I Daud, Smitha S Krishnamurthi, Mansoor N Saleh, Barbara J Gitlitz, Mitesh J Borad, Philip J Gold, Elena G Chiorean, Gregory M Springett, Richat Abbas, Shefali Agarwal,[...]. Clin Cancer Res 2012
48
100

A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies.
H-T Arkenau, R Plummer, L R Molife, D Olmos, T A Yap, M Squires, S Lewis, V Lock, M Yule, J Lyons,[...]. Ann Oncol 2012
41
100

MET inhibitors in combination with other therapies in non-small cell lung cancer.
Sukhmani Padda, Joel W Neal, Heather A Wakelee. Transl Lung Cancer Res 2012
18
100

Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations.
Ning Lv, Xiaoming Xie, Qidong Ge, Suxia Lin, Xi Wang, Yanan Kong, Hongliu Shi, Xinhua Xie, Weidong Wei. Diagn Pathol 2011
25
100

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy.
Marka R Crittenden, Jason Baird, David Friedman, Talicia Savage, Lauren Uhde, Alejandro Alice, Benjamin Cottam, Kristina Young, Pippa Newell, Cynthia Nguyen,[...]. Oncotarget 2016
55
100

Phagocytosis and clearance of apoptotic cells is mediated by MER.
R S Scott, E J McMahon, S M Pop, E A Reap, R Caricchio, P L Cohen, H S Earp, G K Matsushima. Nature 2001
841
100


KPNB1-mediated nuclear translocation of PD-L1 promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signaling pathway.
Wenwen Du, Jianjie Zhu, Yuanyuan Zeng, Ting Liu, Yang Zhang, Tingting Cai, Yulong Fu, Weijie Zhang, Ruochen Zhang, Zeyi Liu,[...]. Cell Death Differ 2021
9
100

Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis.
Juwen C DuBois, Alex K Ray, Peter Davies, Bridget Shafit-Zagardo. J Neuroinflammation 2020
2
100

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.
Jiahui Si, Yuanyuan Ma, Ji Wang Bi, Ying Xiong, Chao Lv, Shaolei Li, Nan Wu, Yue Yang. J Exp Clin Cancer Res 2019
13
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.